Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

24 Jul 2014 07:00

RNS Number : 1641N
Halma PLC
24 July 2014
 



Halma plc

 

AGM/Interim Management Statement

 

24 July 2014

 

 

Halma, the leading safety, health and environmental technology group is holding its 120th AGM later today and makes the following Interim Management Statement relating to the period 30 March 2014 to date, with comments on trading relating to the first quarter ended 28 June 2014.

 

Market conditions have remained varied within our four sectors and the major geographic regions, while the increasing strength of sterling continues to provide a translation headwind. However, Halma has continued to achieve organic revenue growth at constant currency with order intake at 103% of revenue. This, together with the acquisitions completed in the first quarter, has positioned Halma to make further progress in the year ahead in line with the Board's expectations.

 

Process Safety performed well with growth from the USA, Mainland Europe, Middle East and South America offsetting lower revenue from Asia Pacific. The integration of RCS, the pipeline corrosion monitoring business acquired in May 2014, has started well and collaboration with Halma's other Process Safety companies is already underway.

 

The Infrastructure Safety sector made solid progress with encouraging growth in the UK and Mainland Europe. The integration into Halma of Advanced Electronics, the fire safety company acquired in May 2014, is also proceeding well.

 

Our Medical sector had a slow start to the year but is gaining momentum with good underlying growth in the USA and South America. Plasticspritzerei, acquired in May 2014, has been fully integrated into Medicel, the Halma company which manufactures devices for cataract surgery procedures.

 

The Environmental & Analysis sector delivered a mixed performance. Revenue growth in Mainland Europe and Asia Pacific has been encouraging although trading in the USA and UK has been more challenging. UK revenue has been affected by lower spending by water utilities which are now in the final year of their 5-year investment cycle.

 

As reported previously, since the start of the period we have completed three acquisitions and one disposal with a net cash cost of £78m. There have been no other material events or transactions during the period impacting upon the Group's financial position, which remains strong. We continue to identify potential acquisition opportunities which meet our strategic and financial criteria.

 

The half yearly results for the period ending 27 September 2014 are expected to be released on 18 November 2014.

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

 

 

NOTE TO EDITORS

 

1.

Halma develops and markets products used worldwide to protect life and improve the quality of life. The Group comprises four business sectors:

 

● Process Safety

Products which protect assets and people at work.

 

● Infrastructure Safety

Products which detect hazards to protect assets and people in public spaces and commercial buildings.

 

● Medical

Products used to improve personal and public health.

 

● Environmental & Analysis

Products and technologies for analysis in safety, life sciences and environmental markets.

 

The key characteristics of Halma's businesses are that they are based on specialist technology and application knowledge, offering strong growth potential. Many Group businesses are market leaders in their specialist field.

 

2.

High resolution photos of Halma senior management, including Chief Executive Andrew Williams, and images illustrating Halma business activities can be downloaded from its website: www.halma.com. Click on the 'News & Media' link, then 'Image Library'. Photo queries: David Waller +44 (0)1494 721111, e-mail: dwaller@halmapr.com.

 

3.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma plc, in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

4.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMGZNVFMGDZM
Date   Source Headline
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.